Biotech and tech job cuts widen in Bay Area as companies chop workers – Tech Xplore

Click here to sign in with or
Forget Password?
Learn more
share this!
1
1
Share
Email
October 26, 2022
by George Avalos, The Mercury News
Employers have decided to eliminate hundreds of biotech and tech jobs in the East Bay with layoffs at companies in Emeryville and Newark, a fresh round of unsettling job cuts during uncertain economic times.

An estimated 254 jobs are being cut by the end of this year in the East Bay, according to official filings with the state Employment Development Department.
Zymergen intends to eliminate 110 jobs at its main office in Emeryville, the WARN notice to the EDD stated. The Zymergen job cuts are slated to take place around Dec. 19.
Astreya, which provides technology and software services under a contract with Facebook app owner Meta Platforms, has decided to chop 144 positions in Newark. The Astreya employment reductions are scheduled for Nov. 18, the WARN notice stated.
The great majority of the positions affected by the Astreya Partners job cuts are in a category listed as inventory technician.
“Astreya Partners will conduct a mass layoff of its employees assigned to perform services at the Meta Platforms facility located at 7300 Gateway Blvd. in Newark,” Michelle Richard, Astreya vice president of global human resources, stated in the WARN filing to the EDD.
Meta Platforms occupies a warehouse complex at the Newark location.
The job cuts at Zymergen are the latest in a string of staffing reductions at the company, which uses advanced software and artificial intelligence to help it discover and design drugs to combat cancer.
In 2021, Zymergen eliminated 188 jobs, according to a review of the company’s filings with the EDD.
So far this year, Zymergen has disclosed plans to chop another 264 jobs, including the latest round of layoffs that total 110 positions slated for mid-December. The two prior rounds of reductions took place on Sept. 26 and Oct. 24, the WARN notices showed.
“The planned action, when finalized, will be permanent,” Zymergen said in the WARN letter regarding the layoffs scheduled for December.
Employees in the commercial, corporate, operations, drug discovery, finance, technology, human resources, legal and research departments in Emeryville were expected to be affected, Zymergen said.
“No one will have the right to bump or displace other employees, and there is no union representing the affected employees,” Mary Sujo, Zymergen’s vice president of people operations, stated in the WARN filing.

---

---

Explore further
MediaNews Group, Inc.
Distributed by Tribune Content Agency, LLC.
Facebook
Twitter
Email
Feedback to editors
21 hours ago
0
22 hours ago
0
Oct 25, 2022
0
Oct 24, 2022
0
Oct 24, 2022
0
15 hours ago
15 hours ago
16 hours ago
20 hours ago
21 hours ago
21 hours ago
21 hours ago
Oct 13, 2022
Sep 09, 2022
Aug 22, 2022
Sep 01, 2022
Aug 13, 2020
Oct 10, 2022
23 hours ago
Oct 25, 2022
Oct 20, 2022
Sep 29, 2022
Sep 13, 2022
Sep 12, 2022
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Tech Xplore in any form.

Daily science news on research developments and the latest scientific innovations
Medical research advances and health news
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.

source